Expert Care and Top Accolades
A bone marrow transplant replaces unhealthy bone marrow – the tissue inside bones that produces blood-forming cells – with healthy cells that should restore normal blood cell production. Bone marrow transplants are used to treat people with cancers of the blood, bone marrow, and lymph nodes, and other blood and immune disorders.
The Bone Marrow Transplant Program at UT Southwestern is accredited by the Foundation for the Accreditation of Cellular Therapy, which recognizes top-quality patient care. We also have been deemed a national center of excellence by all major national health insurance carriers.
Our experienced physicians, nurses, and other care providers guide patients through every step of the bone marrow transplant process. We strive to deliver the most appropriate and effective care possible, and we’re here to manage care from diagnosis to personalized treatment and beyond.
UT Southwestern offers CAR-T therapy for the treatment of leukemia, lymphoma, and myeloma. CAR-T is immunotherapy in which a patient’s T-cells, a type of white blood cell, are genetically modified to include a chimeric antigen receptor (CAR) that is designed to bind to specific proteins on cancer cells. This reprograms the T-cells to recognize and attack the patient’s specific cancer. We are an approved site for Yescarta and Kymriah immunotherapies for the treatment of lymphoma. Kymriah can also be used to treat leukemia. We are one of just nine U.S. hospitals participating in the most advanced phases of clinical trials of CAR-T therapy for multiple myeloma.